Article Details

Contrasting Statera Biopharma (NASDAQ:STAB) and eFFECTOR Therapeutics (NASDAQ:EFTR)

Retrieved on: 2022-09-29 07:17:26

Tags for this article:

Click the tags to see associated articles and topics

Contrasting Statera Biopharma (NASDAQ:STAB) and eFFECTOR Therapeutics (NASDAQ:EFTR). View article details on hiswai:

Excerpt

Insider and Institutional Ownership. 8.4% of Statera Biopharma shares are owned by institutional investors. Comparatively, 68.9% of eFFECTOR ...

Article found on: reporter.am

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up